These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 1346721)
1. Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat. Ohno M; Yamamoto T; Ueki S Psychopharmacology (Berl); 1992; 106(1):31-8. PubMed ID: 1346721 [TBL] [Abstract][Full Text] [Related]
2. Antitussive effects of two specific kappa-opioid agonists, U-50,488H and U-62,066E, in rats. Kamei J; Tanihara H; Kasuya Y Eur J Pharmacol; 1990 Oct; 187(2):281-6. PubMed ID: 2272363 [TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909 [TBL] [Abstract][Full Text] [Related]
6. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats. Yamamoto T; Ohno M; Ueki S Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist. Yamada K; Imai M; Yoshida S Eur J Pharmacol; 1989 Jan; 160(2):229-37. PubMed ID: 2547626 [TBL] [Abstract][Full Text] [Related]
8. kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats. Shibata S; Tominaga K; Watanabe S Eur J Pharmacol; 1995 Jun; 279(2-3):197-202. PubMed ID: 7556401 [TBL] [Abstract][Full Text] [Related]
9. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Negus SS; Picker MJ; Dykstra LA Psychopharmacology (Berl); 1990; 102(4):465-73. PubMed ID: 1965748 [TBL] [Abstract][Full Text] [Related]
10. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Funada M; Suzuki T; Narita M; Misawa M; Nagase H Neuropharmacology; 1993 Dec; 32(12):1315-23. PubMed ID: 7908722 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Pugsley MK; Penz WP; Walker MJ; Wong TM Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979 [TBL] [Abstract][Full Text] [Related]
12. Effects of naloxone, morphine and kappa-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats. Shibata S; Tominaga K; Watanabe S Neurosci Lett; 1994 Dec; 182(2):155-8. PubMed ID: 7715801 [TBL] [Abstract][Full Text] [Related]
13. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Von Voigtlander PF; Lewis RA Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):467-70. PubMed ID: 6298890 [TBL] [Abstract][Full Text] [Related]
14. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist. Bhargava HN; Ramarao P; Gulati A Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058 [TBL] [Abstract][Full Text] [Related]
15. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986 [TBL] [Abstract][Full Text] [Related]
16. Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure. Picker MJ; Negus SS; Craft RM Pharmacol Biochem Behav; 1990 Jul; 36(3):563-8. PubMed ID: 2165617 [TBL] [Abstract][Full Text] [Related]
17. Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats. Mori T; Yoshizawa K; Ueno T; Nishiwaki M; Shimizu N; Shibasaki M; Narita M; Suzuki T Behav Pharmacol; 2013 Aug; 24(4):275-81. PubMed ID: 23838963 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists. Picker MJ; Dykstra LA J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680 [TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity. Picker MJ; Cook CD Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011 [TBL] [Abstract][Full Text] [Related]
20. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H. Bot G; Chahl LA; Brent PJ; Johnston PA Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]